ProfileGDS4718 / 213808_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 17% 19% 52% 12% 20% 14% 8% 17% 30% 16% 24% 20% 11% 12% 10% 24% 15% 13% 8% 10% 12% 21% 17% 13% 19% 12% 21% 7% 27% 11% 10% 12% 15% 13% 11% 17% 14% 19% 18% 53% 18% 18% 27% 16% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.0396917
GSM549102patient 115, normal, homogenized [OPG study]4.114919
GSM549104patient 119, normal, homogenized [OPG study]5.5966952
GSM549108patient 138, normal, homogenized [OPG study]3.8575112
GSM549119patient 077, normal, homogenized [OPG study]4.1629220
GSM549133patient 032, cancer, homogenized [OPG study]3.8680914
GSM549139patient 042, cancer, homogenized [OPG study]3.680918
GSM549099patient 107, normal, homogenized [OPG study]4.0606417
GSM549109patient 139, normal, homogenized [OPG study]4.5644130
GSM549110patient 046, normal, homogenized [OPG study]3.9943716
GSM549114patient 063, normal, homogenized [OPG study]4.2653924
GSM549122patient 082, normal, homogenized [OPG study]4.1363320
GSM549134patient 033, cancer, homogenized [OPG study]3.8211511
GSM549136patient 036, cancer, homogenized [OPG study]3.8029312
GSM549140patient 044, cancer, homogenized [OPG study]3.7646610
GSM549111patient 047, normal, homogenized [OPG study]4.2571524
GSM549113patient 057, normal, homogenized [OPG study]3.9216715
GSM549132patient 031, cancer, homogenized [OPG study]3.8828213
GSM549137patient 038, cancer, homogenized [OPG study]3.704088
GSM549142patient 047, cancer, homogenized [OPG study]3.8433910
GSM549100patient 110, normal, homogenized [OPG study]3.8682312
GSM549107patient 135, normal, homogenized [OPG study]4.157621
GSM549115patient 068, normal, homogenized [OPG study]3.9815117
GSM549116patient 072, normal, homogenized [OPG study]3.8905313
GSM549120patient 078, normal, homogenized [OPG study]4.0977619
GSM549131patient 030, cancer, homogenized [OPG study]3.8081912
GSM549118patient 074, normal, homogenized [OPG study]4.1792321
GSM549129patient 027, cancer, homogenized [OPG study]3.68187
GSM549123patient 088, normal, homogenized [OPG study]4.416527
GSM549124patient 006, cancer, homogenized [OPG study]3.829511
GSM549126patient 015, cancer, homogenized [OPG study]3.7575710
GSM549128patient 025, cancer, homogenized [OPG study]3.8448512
GSM549103patient 117, normal, homogenized [OPG study]3.9853115
GSM549117patient 073, normal, homogenized [OPG study]3.9020313
GSM549138patient 041, cancer, homogenized [OPG study]3.8041611
GSM549141patient 045, cancer, homogenized [OPG study]3.9823717
GSM549130patient 028, cancer, homogenized [OPG study]3.9344914
GSM549101patient 111, normal, homogenized [OPG study]4.1182919
GSM549105patient 128, normal, homogenized [OPG study]4.0799218
GSM549106patient 134, normal, homogenized [OPG study]5.6490953
GSM549112patient 048, normal, homogenized [OPG study]4.074118
GSM549125patient 011, cancer, homogenized [OPG study]4.0671618
GSM549127patient 024, cancer, homogenized [OPG study]4.3999727
GSM549135patient 035, cancer, homogenized [OPG study]3.9531316